Formononetin inhibits IgE by huPlasma/PBMCs and mast cells/basophil activation via JAK/STAT/PI3-Akt pathways

Formononetin inhibits IgE by huPlasma/PBMCs and mast cells/basophil activation via JAK/STAT/PI3-Akt pathways

RationaleFood allergy is a prevalent disease in the U.S., affecting nearly 30 million people. The primary management strategy for this condition is food avoidance, as limited treatment options are available. The elevation of pathologic IgE and over-reactive mast cells/basophils is a central factor i...

Bibliografiset tiedot
Päätekijät:	Ibrahim Musa, Zhen-Zhen Wang, Nan Yang, Xiu-Min Li
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	Frontiers Media S.A. 2024-08-01
Sarja:	Frontiers in Immunology
Aiheet:	formononetin food anaphylaxis computational modeling target mining molecular docking gene ontology enrichment
Linkit:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1427563/full

Samankaltaisia teoksia

Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials
Tekijä: Jiao Tian, et al.
Julkaistu: (2022-05-01)

Anxiolytic effects of Formononetin in an inflammatory pain mouse model
Tekijä: Xin-shang Wang, et al.
Julkaistu: (2019-04-01)

Formononetin: A Pathway to Protect Neurons
Tekijä: Xiaoyu Ma, et al.
Julkaistu: (2022-07-01)

Related substance determination of formononetin by HPLC
Tekijä: Xingyan PAN, et al.
Julkaistu: (2017-02-01)

Formononetin: A Review of Its Anticancer Potentials and Mechanisms
Tekijä: Kai-Ching Tay, et al.
Julkaistu: (2019-07-01)

The Proapoptotic Effect of Formononetin in Human Osteosarcoma Cells: Involvement of Inactivation of ERK and Akt Pathways
Tekijä: Yun Liu, et al.
Julkaistu: (2014-08-01)

The Role of Formononetin in Osteoblast Function and Mineralization Potential with Deproteinized Bovine Bone Material
Tekijä: Ebru Haciosmanoglu Aldogan, et al.
Julkaistu: (2024-12-01)

Formononetin Inhibits Mast Cell Degranulation to Ameliorate Compound 48/80-Induced Pseudoallergic Reactions
Tekijä: Zi-Wen Zhou, et al.
Julkaistu: (2023-07-01)

Cartilage-targeting poly(ethylene glycol) (PEG)-formononetin (FMN) nanodrug for the treatment of osteoarthritis
Tekijä: Wei Xiong, et al.
Julkaistu: (2021-07-01)

Potential mechanisms of formononetin against inflammation and oxidative stress: a review
Tekijä: Meiling Ding, et al.
Julkaistu: (2024-05-01)

Formononetin isolated from Sophorae flavescentis inhibits B cell-IgE production by regulating ER-stress transcription factor XBP-1
Tekijä: Nan Yang, et al.
Julkaistu: (2023-02-01)

Research Progress of Formononetin for Anticancer Drug Development
Tekijä: WANG Ruyue, et al.
Julkaistu: (2019-02-01)

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
Tekijä: Zhuo Liu, et al.
Julkaistu: (2025-01-01)

Parent-Metabolite Pharmacokinetic Modeling of Formononetin and Its Active Metabolites in Rats after Oral Administration of Formononetin Formulations
Tekijä: Ju Hee Kim, et al.
Julkaistu: (2022-12-01)

Formononetin Exerts Neuroprotection in Parkinson’s Disease via the Activation of the Nrf2 Signaling Pathway
Tekijä: Xiaotong Wang, et al.
Julkaistu: (2024-11-01)

The neuroprotective effects of formononetin: Signaling pathways and molecular targets
Tekijä: Long-Mei Geng, et al.
Julkaistu: (2022-01-01)

A Study of the Mechanisms and Characteristics of Fluorescence Enhancement for the Detection of Formononetin and Ononin
Tekijä: Jinjin Cao, et al.
Julkaistu: (2023-02-01)

The possible antioxidant capabilities of formononetin in guarding against streptozotocin-induced diabetic nephropathy in rats
Tekijä: Pankaj G. Jain, et al.
Julkaistu: (2020-08-01)

Formononetin Promotes Cell Cycle Arrest via Downregulation of Akt/Cyclin D1/CDK4 in Human Prostate Cancer Cells
Tekijä: Tianyu Li, et al.
Julkaistu: (2014-10-01)

Effect of Formononetin on Lipopolysaccharide-Induced Depressive-Like Behaviors and Neuroinflammation in Mice
Tekijä: Mengyuan Li, et al.
Julkaistu: (2023-09-01)

Using the Cocrystal Approach as a Promising Drug Delivery System to Enhance the Dissolution and Bioavailability of Formononetin Using an Imidazole Coformer
Tekijä: Jongyeob Kim, et al.
Julkaistu: (2024-10-01)

Preliminary study on conjugation of formononetin with multiwalled carbon nanotubes for inducing apoptosis via ROS production in HeLa cells
Tekijä: Guo B, et al.
Julkaistu: (2018-09-01)

In silico and in vivo verification of the mechanism of formononetin in treating hepatocellular carcinoma
Tekijä: Guiping Ma, et al.
Julkaistu: (2024-12-01)

Formononetin Upregulates Nrf2/HO-1 Signaling and Prevents Oxidative Stress, Inflammation, and Kidney Injury in Methotrexate-Induced Rats
Tekijä: Saleem H. Aladaileh, et al.
Julkaistu: (2019-09-01)

Simultaneous Determination of Daidzein, Genistein and Formononetin in Coffee by Capillary Zone Electrophoresis
Tekijä: Feng Luan, et al.
Julkaistu: (2017-01-01)

Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems
Tekijä: Min Jin, et al.
Julkaistu: (2025-03-01)

Formononetin associated with phosphorus influences soybean symbiosis with mycorrhizal fungi and Bradyrhizobium
Tekijä: Paula Rose de Almeida Ribeiro, et al.
Julkaistu: (2016-07-01)

Elucidating the mechanisms of formononetin in modulating atherosclerotic plaque formation in ApoE-/- mice
Tekijä: Ying He, et al.
Julkaistu: (2024-02-01)

Albumin-based formononetin nanomedicines for lung injury and fibrosis therapy via blocking macrophage pyroptosis
Tekijä: Boshu Ouyang, et al.
Julkaistu: (2023-06-01)

Effects of formononetin on the expression of orexin and calcitonin gene-related peptide genes in a stress model rats
Tekijä: Elaheh Basirat, et al.
Julkaistu: (2024-12-01)

Formononetin promotes porcine oocytes maturation and improves embryonic development by reducing oxidative stress
Tekijä: Na Wang, et al.
Julkaistu: (2025-01-01)

Formononetin and Dihydroartemisinin Act Synergistically to Induce Apoptosis in Human Acute Myeloid Leukemia Cell Lines
Tekijä: Yusef Abbasi, et al.
Julkaistu: (2024-02-01)

Formononetin alleviates diabetic cardiomyopathy by inhibiting oxidative stress and upregulating SIRT1 in rats
Tekijä: Manisha J Oza, et al.
Julkaistu: (2020-01-01)

Formononetin exhibits anticancer activity in gastric carcinoma cell and regulating miR‐542‐5p
Tekijä: Wei‐Song Wang, et al.
Julkaistu: (2021-03-01)

Formononetin Protects LPS-Induced Mastitis Through Suppressing Inflammation and Enhancing Blood-Milk Barrier Integrity via AhR-Induced Src Inactivation
Tekijä: Kaihe Xiang, et al.
Julkaistu: (2022-02-01)

Renoprotective Effect of Formononetin by Suppressing Smad3 Expression in Db/Db Mice
Tekijä: Lv J, et al.
Julkaistu: (2020-09-01)

Formononetin Treatment in Type 2 Diabetic Rats Reduces Insulin Resistance and Hyperglycemia
Tekijä: Manisha J. Oza, et al.
Julkaistu: (2018-07-01)

Formononetin Ameliorates Renal Dysfunction, Oxidative Stress, Inflammation, and Apoptosis and Upregulates Nrf2/HO-1 Signaling in a Rat Model of Gentamicin-Induced Nephrotoxicity
Tekijä: Osama Y. Althunibat, et al.
Julkaistu: (2022-05-01)

Formononetin reverses Treg/Th17 imbalance in immune-mediated bone marrow failure mice by regulating the PI3K/Akt signaling pathway
Tekijä: Huixuan Lan, et al.
Julkaistu: (2024-03-01)

Characterization of Formononetin Sulfonation in SULT1A3 Overexpressing HKE293 Cells: Involvement of Multidrug Resistance-Associated Protein 4 in Excretion of Sulfate
Tekijä: Fanye Liu, et al.
Julkaistu: (2021-01-01)